Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease–associated renal cell carcinoma: Post hoc analysis of the LITESPARK-004 study.
Autor: | Maughan, Benjamin L., Srinivasan, Ramaprasad, Iliopoulos, Othon, Bundsbæk Bøndergaard Iversen, Ane, Narayan, Vivek, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K., Beckermann, Katy, Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Jonasch, Eric |
---|---|
Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p3-3, 5p |
Databáze: | Supplemental Index |
Externí odkaz: |